Dr. Vanderver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-1771
Education & Training
- Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 2001 - 2004
- Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 1999 - 2001
- Temple University HospitalInternship, Pediatrics, 1998 - 1999
- University Cath De LouvainClass of 1998
Certifications & Licensure
- VA State Medical License 2022 - 2026
- MD State Medical License 2004 - 2025
- NJ State Medical License 2022 - 2025
- NC State Medical License 2022 - 2024
- PA State Medical License 1999 - 2024
- NY State Medical License 2022 - 2023
- DC State Medical License 2004 - 2020
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- The Nosology and Etiology of Leukodystrophies of Unknown Causes Start of enrollment: 2009 Apr 24
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
- Natural History Study of Children With Metachromatic Leukodystrophy Start of enrollment: 2015 Nov 02
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsGJC2 promoter mutations causing Pelizaeus-Merzbacher-like diseaseLeo Gotoh, Ken Inoue, Guy Helman, Sara Mora, Kiran Maski
Molecular Genetics and Metabolism. 2014-03-01 - 122 citationsRecessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase IIIIsabelle Thiffault, Nicole I. Wolf, Diane Forget, Kether Guerrero, Luan T. Tran
Nature Communications. 2015-07-07 - 143 citationsClinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutationsNicole I. Wolf, Adeline Vanderver, Rosalina M. L. van Spaendonk, Raphael Schiffmann, Bernard Brais
Neurology. 2014-11-18
Journal Articles
- Author Correction: Neuroimmune Disorders of the Central Nervous System in Children in the Molecular EraAdeline Vanderver, Beau Ances, Benjamin Greenberg, Ann Hyslop, Mark Gorman, Elizabeth Wells, Sean Pittock, Amy Waldman, Brenda Banwell, Nature
- Health-Related Quality of Life for Patients with Genetically Determined LeukoencephalopathyAdeline Vanderver, Raphael Schiffmann, Pediatric Neurology
Authored Content
- Health-Related Quality of Life for Patients with Genetically Determined LeukoencephalopathyMay 2018
Press Mentions
- Existing Drugs May Improve Neurological Function in Patients with Rare Genetic DisorderSeptember 2nd, 2020
- My Girl, 11, Can’t Walk After a Rare Disease Robbed Her of Her Future – Now I’ve Helped Raise £75k to Help Find a CureAugust 11th, 2020
- Baricitinib May Benefit Patients with Aicardi-Goutières SyndromeOctober 28th, 2019
- Join now to see all
Grant Support
- Molecular Mechanisms In Vanishing White Matter DiseaseNational Institute Of Neurological Disorders And Stroke2009–2012
- New Diagnostic Approaches In LeukodystrophyNational Center For Research Resources2007–2008
- Improved Diagnosis Of Unclassified LeukodystrophiesNational Center For Research Resources2006–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: